Macular Pseudohole Development after Sustained-Release Dexamethasone Intravitreal Implant for Macular Edema Due to Central Retinal Vein Occlusion

Abstract

Purpose

To report a case of macular pseudohole (MPH) development after sustained-release dexamethasone intravitreal implant for chronic macular edema due to central retinal vein occlusion (CRVO).

Methods

A 70-year-old man with cystoid macular edema (CME) due to CRVO underwent sustained-release dexamethasone intravitreal implant. En face optical coherence tomography (OCT) was performed before and after treatment.

Results

One month after dexamethasone intravitreal implant, best-corrected visual acuity (BCVA) improved from 1.0 to 0.5 logMAR. At 2 months, BCVA decreased from 0.5 to 1.3 logMAR. En face OCT detected the development of MPH due to exacerbation of centripetal vitreomacular transverse tractional forces on the overlying retina.

Conclusions

Macular pseudohole seems to be a complication of intravitreal therapy in patients with coexisting vitreomacular traction. En face OCT gives useful information to understand the mechanism of MPH development after sustained-release dexamethasone intravitreal implant.

Keywords

En face optical coherence tomography Macular pseudohole Sustained-release dexamethasone intravitreal implant

Get full access to this article

View all access options for this article.

References

Haller

J.A.

, Bandello

, Belfort

Jr. . OZURDEX GENEV A Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010; 117: 1134–46.

Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: The Central Vein Occlusion Study Group M Report. Ophthalmology 1995; 102: 1425–33.

Coscas

, Loewenstein

, Augustin

. Management of retinal vein occlusion: consensus document. Ophthalmologica 2011; 226: 4–28.

Parodi

M.B.

, Iacono

, Cascavilla

, Zucchiatti

, Bandello

. Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting. Acta Ophthalmol 2012; 90: e322–3.

Lattanzio

, Ramoni

, Scotti

, Introini

. Macular hole and intravitreal injection of triamcinolone acetonide for macular edema due to central retinal vein occlusion. Eur J Ophthalmol 2007; 17: 451–3.

De Benedetto

, Battaglia Parodi

, Anders Knutsson

. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion. Acta Ophthalmol 2013; 91: e75–7.

Podoleanu

A.G.

, Dobre

G.M.

, Cucu

R.G.

. Combined multiplanar optical coherence tomography and confocal scanning ophthalmoscopy. J Biomed Opt 2004; 9: 86–93.

Tammewar

A.M.

, Bartsch

D-U

, Kozak

. Imaging vitreomacular interface abnormalities in the coronal plane by simultaneous combined scanning laser and optical coherence tomography. Br J Ophthalmol 2009; 93: 366–72.

Allen

A.W.

Jr. , Gass

J.D.

. Contraction of a perifoveal epiretinal membrane simulating a macular hole. Am J Ophthalmol 1976; 82: 684–91.

10.

Massin

, Paques

, Masri

. Visual outcome of surgery for epiretinal membranes with macular pseudoholes. Ophthalmology 1999; 106: 580–5.

11.

Decross

F.C.

, Shuler

R.K.

Jr. , Stinnett

. Pars plana vitrectomy, internal limiting membrane, and panretinal endophotocoagulation for macular edema secondary to central vein occlusion. Am J Ophthalmol 2009; 147: 627–33.

12.

Parodi

M.B.

, Iacono

, De Benedetto

. Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion. J Ocul Pharmacol Ther 2012; 28: 566–8.